Safety study of HW241045 in healthy adults
Part of Lungs & breathing clinical trials.
This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 55 years old.
- Females need to weigh at least 99 pounds (45 kg), and males at least 110 pounds (50 kg).
- Your body mass index (BMI) should be between 19 and 26.
- You cannot have any serious or chronic medical conditions (like heart, liver, or kidney disease).
- You cannot have had major surgery or injury in the last 3 months.
- You cannot have a history of drug or food allergies that could interfere with the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug, HW252001, in healthy volunteers to see how safe it is and how the body handles it. If you qualify, you would help researchers find the right dose for future studies.
This study tests a new experimental drug (HW243040) in healthy volunteers to see if it is safe and how the body handles it. It includes pain testing to measure how the drug works on pain.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new drug called HW243040 in healthy adults to see how safe it is. It helps researchers understand how the drug works in the body before testing it in patients with a condition.
This study is testing a new investigational drug called HW241045 in healthy volunteers. The main goal is to check how the drug is processed by the body and whether it is safe, which helps find the right dose for future studies.
This trial tests a new medicine called HSK47388 to see if it is safe and how the body processes it. It is an early-stage study in healthy adults aged 18 to 55.
Hear when a new IPF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.